Pharmaxis announces sustained benefit in cystic fibrosis following long term bronchitol treatment
17th
May 10
Release Date: 17/05/2010 12:00am
Pharmaxis today announced significant headline results for the final stage of its international Phase III trial of Bronchitol (inhaled mannitol) in people with cystic fibrosis.
Categories: News and Media